Does CABIRALIZUMAB Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with CABIRALIZUMAB. This represents 8.2% of all adverse event reports for CABIRALIZUMAB.
5
Reports of Malignant neoplasm progression with CABIRALIZUMAB
8.2%
of all CABIRALIZUMAB reports
5
Deaths
5
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CABIRALIZUMAB?
Of the 5 reports, 5 (100.0%) resulted in death, 5 (100.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABIRALIZUMAB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does CABIRALIZUMAB Cause?
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)